Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial
Publication
, Conference
Siegbahn, A; Hijazi, Z; Lindback, J; Oldgren, J; Pol, T; Alexander, JH; Lopes, RD; Granger, CB; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2018
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2018
Volume
39
Start / End Page
1007 / 1007
Location
Munich, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
European-Society-of-Cardiology Congress
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Siegbahn, A., Hijazi, Z., Lindback, J., Oldgren, J., Pol, T., Alexander, J. H., … Wallentin, L. (2018). Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 39, pp. 1007–1007). Munich, GERMANY: OXFORD UNIV PRESS.
Siegbahn, A., Z. Hijazi, J. Lindback, J. Oldgren, T. Pol, J. H. Alexander, R. D. Lopes, C. B. Granger, and L. Wallentin. “Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 39:1007–1007. OXFORD UNIV PRESS, 2018.
Siegbahn A, Hijazi Z, Lindback J, Oldgren J, Pol T, Alexander JH, et al. Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2018. p. 1007–1007.
Siegbahn, A., et al. “Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 39, OXFORD UNIV PRESS, 2018, pp. 1007–1007.
Siegbahn A, Hijazi Z, Lindback J, Oldgren J, Pol T, Alexander JH, Lopes RD, Granger CB, Wallentin L. Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2018. p. 1007–1007.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2018
Volume
39
Start / End Page
1007 / 1007
Location
Munich, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
European-Society-of-Cardiology Congress
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology